{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P50591",
      "entity_text" : "TRAIL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Thus, this triallelic combination might result in target cells, such as oligodendrocytes, remaining resistant to TRAIL induced apoptosis, which might be one of the putative cytotoxic effector mechanisms in MS pathogenesis.",
  "reading_complete" : "2020-07-28T17:15:03Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:14:06Z",
  "trigger" : "induced",
  "evidence" : [ "TRAIL-induced apoptosis" ],
  "pmc_id" : "3140982",
  "score" : 0
}